year
sinc
outbreak
sever
acut
respiratori
syndrom
sar
caus
novel
coronaviru
subsequ
name
sar
coronaviru
sarscov
peiri
et
al
sarscov
phylogenet
diverg
known
coronavirus
associ
human
infect
includ
human
coronaviru
hcov
middl
east
respiratori
syndrom
coronaviru
merscov
close
relat
civet
bat
sarscov
group
lineag
b
betacoronavirus
found
civet
raccoon
dog
ferret
badger
chines
horsesho
bat
rhinolophu
sinicu
guangdong
provinc
south
china
chan
et
al
chines
horsesho
bat
appear
natur
reservoir
ancestr
sarscov
kak
ratio
rate
nonsynonym
mutationr
synonym
mutat
gene
low
civet
strain
minor
outbreak
high
suggest
rapidli
evolv
process
gene
adapt
anim
lau
et
al
li
et
al
sar
emerg
outbreak
atyp
acut
communityacquir
pneumonia
late
initi
case
anim
handler
guangzhou
provinc
regular
contact
wild
game
food
anim
suggest
civet
could
serv
intermedi
amplif
host
later
patient
close
household
hospit
contact
human
sarscov
subsequ
evolv
capabl
persontoperson
transmiss
epidem
rapidli
global
dissemin
medic
professor
teach
hospit
guangzhou
consid
superspread
sar
came
hong
kong
februari
stay
hotel
transmit
infect
resid
secondari
case
spread
diseas
hospit
hong
kong
countri
includ
vietnam
singapor
canada
eventu
total
patient
infect
countri
among
contin
die
cheng
et
al
known
effect
antivir
agent
sar
support
care
use
broadspectrum
antibiot
cover
secondari
bacteri
infect
key
treatment
regimen
use
exist
antivir
therapi
includ
convent
one
like
ribavirin
interferon
alpha
infacon
convalesc
plasma
inhibitori
effect
sarscov
lopinavir
ritonavir
without
corticosteroid
use
report
nonrandom
clinic
trial
sinc
clinic
efficaci
antivir
agent
found
uncertain
retrospect
analysi
leong
et
al
effect
public
health
infect
control
measur
includ
contact
trace
quarantin
close
contact
play
import
role
prevent
transmiss
sar
commun
hospit
pang
et
al
svoboda
et
al
intern
collabor
unit
laboratori
differ
technolog
capac
allow
research
laboratori
rapidli
fulfil
postul
establish
sarscov
caus
sar
epidem
came
end
transmiss
sar
taiwan
juli
cheng
et
al
howev
brief
reemerg
che
et
al
accident
laboratori
exposur
singapor
taiwan
beij
recurr
animaltohuman
transmiss
guangzhou
late
earli
liang
et
al
lim
et
al
normil
b
pose
potenti
threat
public
health
incub
period
sar
gener
day
occasion
case
day
famili
cohort
hong
kong
patient
admit
hospit
day
onset
symptom
donnelli
et
al
typic
clinic
present
includ
fever
chill
rigor
cough
headach
myalgia
fatigu
malais
wherea
sore
throat
rhinorrhea
dizzi
chest
pain
less
frequent
seen
tabl
howev
symptom
may
milder
children
atyp
present
without
fever
may
occur
elderli
patient
fisher
et
al
kwan
et
al
rare
healthi
young
adult
woo
et
al
diarrhea
present
occur
patient
asia
north
america
respect
patient
mean
day
onset
symptom
commun
cohort
peiri
et
al
posit
correl
higher
mean
viral
load
nasopharyng
specimen
higher
initi
viral
load
independ
associ
wors
prognosi
sar
rapid
respiratori
deterior
observ
one
week
onset
ill
patient
progress
acut
respiratori
distress
syndrom
ard
requir
mechan
ventil
peiri
et
al
radiograph
featur
sar
similar
viral
pneumonia
groundglass
opac
focal
consolid
demonstr
chest
radiograph
predominantli
involv
peripher
subpleur
region
lower
zone
grinblat
et
al
hsieh
et
al
lai
et
al
spontan
pneumomediastium
found
case
wherea
patient
develop
barotrauma
mechan
ventil
gomersal
et
al
addit
upper
lower
respiratori
tract
diseas
extrapulmonari
manifest
also
report
sar
includ
liver
renal
impair
chau
et
al
chu
et
al
bradycardia
hypotens
due
diastol
cardiac
dysfunct
pulmonari
arteri
thrombosi
rhabdomyolysi
wang
et
al
neuromuscular
disord
tsai
et
al
acut
neurolog
syndrom
statu
epilepticu
lau
et
al
lymphopenia
leucopenia
thrombocytopenia
commonli
observ
diagnost
criteria
sar
base
list
clinic
featur
suggest
world
health
organ
center
diseas
control
prevent
cdc
initi
phase
epidem
accord
criteria
suspect
case
defin
person
present
novemb
histori
fever
cough
difficulti
breath
close
contact
person
suspect
probabl
case
sar
histori
travel
resid
area
transmiss
sar
within
day
onset
symptom
addit
person
unexplain
acut
respiratori
ill
result
death
epidemiolog
exposur
similar
describ
autopsi
perform
also
fulfil
clinic
criteria
suspect
sar
probabl
case
sar
defin
suspect
case
chest
xray
evid
infiltr
consist
pneumonia
acut
respiratori
distress
syndrom
posit
test
result
sarscov
one
laboratori
diagnost
assay
andor
autopsi
find
consist
patholog
ard
without
identifi
caus
overal
accuraci
guidelin
identifi
suspect
sar
found
neg
predict
valu
rainer
et
al
fan
et
al
hsu
et
al
jang
et
al
lee
et
al
liang
et
al
peiri
et
al
peiri
et
al
rainer
et
al
et
al
tsang
et
al
tsang
et
al
vu
et
al
yeh
et
al
zhao
et
al
refer
sar
north
america
booth
et
al
poutanen
et
al
laboratori
case
definit
diagnosi
reemerg
sar
set
epidem
person
clinic
suggest
symptom
sign
one
posit
laboratori
find
includ
revers
transcriptasepolymeras
chain
reaction
rtpcr
posit
sarscov
use
valid
method
least
two
differ
clinic
specimen
clinic
specimen
collect
two
occas
cours
ill
two
differ
assay
differ
gene
target
repeat
rtpcr
use
new
rna
extract
origin
clinic
sampl
occas
test
seroconvers
enzymelink
immunosorb
assay
elisa
indirect
fluoresc
antibodi
ifa
assay
isol
cell
cultur
sarscov
specimen
rtpcr
confirm
use
valid
method
cdc
case
definit
sar
also
base
combin
clinic
epidemiolog
laboratori
criteria
exclus
criteria
case
altern
diagnosi
could
fulli
explain
ill
convalesc
phase
serum
sampl
obtain
day
symptom
onset
neg
antibodi
sarscov
case
report
basi
contact
index
patient
subsequ
exclud
case
provid
possibl
epidemiolog
exposur
criteria
avail
cdc
rapid
laboratori
diagnosi
mostli
reli
nucleic
acid
amplif
assay
use
sarscov
open
read
frame
nucleoprotein
gene
target
detect
respiratori
specimen
stool
urin
blood
lung
tissu
lau
et
al
poon
et
al
poon
et
al
poon
et
al
diagnosi
rare
reli
enzym
immunoassay
eia
viral
nucleocapsid
protein
antigen
detect
patient
sera
che
et
al
che
et
al
lau
et
al
nucleoprotein
np
gene
protein
chosen
target
rtpcr
eia
np
abundantli
express
mrna
protein
infect
cell
therefor
give
higher
sensit
realtim
quantit
rtpcr
nasopharyng
aspir
found
sensit
even
specimen
collect
within
first
day
symptom
onset
poon
et
al
shed
viru
correl
clinic
cours
among
sar
patient
serial
collect
nasopharyng
aspir
day
symptom
onset
viral
load
peak
around
day
invert
v
pattern
peiri
et
al
addit
respiratori
stool
sampl
quantit
measur
viral
load
also
perform
specimen
includ
serum
urin
saliva
hung
et
al
detect
viru
rtpcr
could
persist
day
lung
tissu
farca
et
al
therapi
proven
effect
random
control
trial
support
treatment
play
import
role
treatment
sar
sinc
etiolog
agent
sar
unknown
initi
phase
epidem
patient
given
empir
antibiot
treatment
communityacquir
pneumonia
coverag
typic
atyp
bacteri
pathogen
et
al
broadspectrum
antibiot
indic
patient
develop
nosocomi
bacteremia
catheterrel
sepsi
nosocomi
pneumonia
due
escherichia
coli
klebsiella
pneumonia
stenotrophomona
maltophilia
peiri
et
al
effect
antivir
agent
need
control
viral
replic
henc
inflamm
tissu
damag
high
viral
load
posit
correl
develop
organ
failur
death
subsequ
studi
hung
et
al
identif
sarscov
etiolog
agent
sar
neuraminidas
inhibitor
oseltamivir
also
prescrib
patient
toronto
singapor
obvious
unlik
affect
prognosi
booth
et
al
hsu
et
al
poutanen
et
al
anoth
broad
spectrum
antivir
agent
ribavirin
purin
nucleosid
analogu
inhibit
guanosin
triphosph
synthesi
viral
rna
polymeras
activ
commonli
given
patient
asia
north
america
patient
descript
medic
treatment
sar
report
literatur
receiv
ribavirin
either
primari
treatment
regimen
combin
corticosteroid
antivir
agent
lopinavirritonavir
tabl
regimen
ribavirin
includ
initi
therapi
antivir
immunomodul
ribavirin
bitnun
et
al
chiu
et
al
hsu
et
al
leong
et
al
poutanen
et
al
zhao
et
al
b
c
ribavirin
corticosteroid
without
puls
steroid
clinic
deterior
booth
et
al
chiu
et
al
choi
et
al
ho
et
al
hon
et
al
lau
et
al
peiri
et
al
peiri
et
al
et
al
sung
et
al
tsang
et
al
tsang
et
al
wang
et
al
lopinavirritonavir
ribavirin
corticosteroid
chu
et
al
e
corticosteroid
alon
loutfi
et
al
wang
et
al
interferon
corticosteroid
loutfi
et
al
zhao
et
al
recombin
interferon
alpha
rescu
therapi
antivir
immunomodul
lopinavirritonavir
convalesc
plasma
immunoglobulin
lew
et
al
lin
et
al
pentaglobulin
ho
et
al
integr
chines
western
medicin
lin
et
al
liu
et
al
addit
empir
antibacteri
agent
oseltamivir
b
includ
pediatr
case
c
includ
pediatr
case
includ
pediatr
case
e
report
case
also
report
intraven
formul
mgkg
everi
h
day
intraven
formul
mgkg
everi
h
day
follow
oral
formul
mg
everi
h
total
day
intraven
load
dose
g
follow
intraven
formul
g
everi
h
day
mg
everi
h
day
oral
formul
g
one
dose
follow
g
everi
h
day
booth
et
al
peiri
et
al
sung
et
al
howev
role
ribavirin
remain
uncertain
obviou
clinic
benefit
retrospect
uncontrol
cohort
analysi
involv
patient
singapor
leong
et
al
although
vitro
studi
also
demonstr
ribavirin
signific
activ
sarscov
vero
cell
cinatl
et
al
ribavirin
good
activ
test
human
pig
kidney
cell
line
moreov
ribavirin
shown
synergist
interferon
vitro
combin
assay
low
level
vitro
activ
sarscov
might
attribut
cellular
toxic
cytotox
dose
ribavirin
variou
cell
line
report
approxim
lgml
advers
effect
ribavirin
uncommon
cohort
patient
toronto
doserel
hemolyt
anemia
observ
patient
wherea
hypocalcaemia
hypomagnesaemia
report
respect
knowl
et
al
anoth
cohort
patient
taiwan
patient
drop
hemoglobin
level
day
therapi
ribavirin
found
independ
prognost
factor
hypoxemia
mortal
chiou
et
al
patient
treat
boost
hiv
proteas
inhibitor
combin
lopinavir
ritonavir
either
initi
therapi
rescu
therapi
along
ribavirin
evolv
epidem
chu
et
al
vitro
antivir
suscept
test
show
cytopath
effect
sarscov
inhibit
lopinavir
lgml
ribavirin
lgml
h
incub
inhibit
cytopath
effect
achiev
lopinavir
concentr
lgml
combin
ribavirin
lgml
viral
inoculum
reduc
tcid
suggest
potenti
synergist
activ
addit
lopinavirritonavir
initi
treatment
associ
reduct
overal
death
rate
intub
rate
compar
match
cohort
receiv
standard
treatment
ribavirin
respect
p
howev
use
lopinavir
ritonavir
rescu
therapi
show
differ
overal
death
rate
rate
oxygen
desatur
intub
compar
match
cohort
subgroup
analysi
view
weak
antivir
activ
proteas
inhibitor
studi
done
ascertain
whether
clinic
benefit
could
attribut
antiapoptot
rather
antivir
activ
matarres
et
al
earli
phase
sar
epidem
identif
caus
agent
histopatholog
chang
open
lung
biopsi
specimen
suggest
possibl
immunopatholog
damag
nichol
et
al
immunomodul
includ
corticosteroid
convalesc
plasma
pentaglobulin
therefor
empir
use
initi
rescu
treatment
initi
therapi
corticosteroid
without
antivir
therapi
initi
patient
loutfi
et
al
wang
et
al
recombin
interferonalpha
given
combin
corticosteroid
interferon
given
loutfi
et
al
zhao
et
al
preliminari
uncontrol
studi
patient
toronto
patient
treat
corticosteroid
alon
patient
treat
corticosteroid
interferon
among
corticosteroid
group
requir
intens
care
requir
mechan
ventil
one
die
mortal
among
corticosteroid
plu
interferon
group
patient
requir
intens
care
mechan
ventil
respect
addit
combin
corticosteroid
interferon
appear
result
improv
oxygen
requir
faster
resolut
chest
radiograph
abnorm
loutfi
et
al
howev
vitro
suscept
test
interferon
sarscov
show
inconsist
result
cinatl
et
al
hensley
et
al
stroher
et
al
although
inhibit
cytopath
effect
sarscov
cultur
observ
leukocyt
interferona
treatment
interferonc
synergist
inhibit
sarscov
plaqu
format
replic
h
fold
h
postinfect
vero
cell
sainz
et
al
prophylact
treatment
sarscovinfect
macaqu
pegyl
interferonalpha
reduc
viral
replic
excret
viral
antigen
express
type
pneumocyt
haagman
et
al
longitudin
serial
viral
load
profil
sarscov
cours
infect
known
corticosteroid
therapi
often
use
togeth
ribavirin
without
avail
extracorpor
membran
oxygen
ecmo
puls
steroid
also
given
rescu
therapi
patient
clinic
deterior
increas
short
breath
oxygen
desatur
radiolog
worsen
despit
ventil
support
peiri
et
al
variou
regimen
corticosteroid
therapi
use
tsang
et
al
standard
treatment
protocol
adult
sar
patient
compris
tail
dose
intraven
methylprednisolon
mgkg
everi
h
oral
prednisolon
mgkg
throughout
cours
day
propos
et
al
retrospect
analysi
sar
patient
show
among
patient
initi
receiv
puls
dose
methylprednisolon
mgday
lower
oxygen
requir
better
radiograph
outcom
compar
anoth
patient
initi
receiv
nonpuls
dose
methylprednisolon
mgday
even
though
cumul
steroid
dosag
intens
care
unit
admiss
mechan
ventil
mortal
rate
hematolog
biochem
paramet
similar
group
day
ho
et
al
retrospect
analysi
guangzhou
corticosteroid
treatment
shown
lower
overal
mortal
shorten
hospit
stay
critic
ill
sar
patient
howev
shortand
longterm
complic
dissemin
fungal
infect
avascular
necrosi
bone
associ
prolong
highdos
corticosteroid
use
treatment
sar
frequent
report
adult
children
hong
du
wang
et
al
longitudin
follow
patient
mainli
healthcar
worker
treat
corticosteroid
develop
avascular
necrosi
hip
within
month
start
treatment
patient
avascular
necrosi
year
follow
number
osteonecrot
lesion
directli
relat
dosag
corticosteroid
peak
dose
mg
cumul
methylprednisoloneequival
dose
mg
signific
risk
factor
multifoc
osteonecrosi
epiphys
diaphys
lesion
zhang
et
al
stage
random
control
trial
data
use
steroid
avail
therefor
treatment
recommend
especi
ecmo
avail
neutral
antibodi
respons
consist
report
patient
recov
sar
convalesc
plasma
collect
patient
may
use
treatment
sever
ill
patient
among
sar
patient
receiv
convalesc
plasma
hong
kong
higher
discharg
rate
observ
patient
treat
day
ill
vs
p
patient
posit
rtpcr
sarscov
antibodi
time
plasma
infus
vs
p
three
healthcar
worker
receiv
convalesc
plasma
therapi
taiwan
viral
load
blood
sampl
drop
copiesml
undetect
level
one
day
transfus
yeh
et
al
pentaglobin
igmenrich
immunoglobulin
prepar
given
sever
ill
sar
patient
continu
deterior
despit
corticosteroid
ribavirin
therapi
signific
improv
radiograph
score
oxygen
requir
commenc
pentaglobin
treatment
patient
made
unev
recoveri
ho
et
al
report
advers
event
attribut
pentaglobin
administr
compar
use
highdos
intraven
gamma
globulin
gkgday
consecut
day
may
associ
deep
venou
thrombosi
pulmonari
embol
lew
et
al
thymic
peptid
recombin
human
thymu
protein
also
given
patient
uncertain
clinic
benefit
tradit
chines
medic
use
treatment
sar
mainland
china
except
glycyrrhizin
activ
compon
liquoric
root
shown
vitro
activ
sarscov
cinatl
et
al
regimen
chines
medicin
independ
assess
vitro
nevertheless
patient
given
chines
medicin
adjunct
therapi
epidem
mainland
china
tabl
gener
chines
medicin
use
modul
restor
immun
system
elimin
toxin
result
sar
without
random
control
trial
data
difficult
assess
efficaci
especi
heterogen
mixtur
differ
compon
chines
medicin
use
lin
et
al
liu
et
al
like
respiratori
viru
infect
sar
predominantli
transmit
respiratori
droplet
direct
contact
infecti
secret
contact
contamin
fomit
view
superspread
phenomenon
index
patient
hong
kong
lead
global
dissemin
sar
airborn
transmiss
sarscov
consid
possibl
special
circumst
roy
milton
numer
studi
done
identifi
potenti
risk
factor
transmiss
commun
hospit
set
tabl
casecontrol
studi
conduct
beij
investig
risk
factor
commun
transmiss
among
person
without
known
contact
sar
patient
found
consist
wear
mask
outdoor
associ
risk
reduct
compar
wear
mask
consist
wash
hand
return
home
show
smaller
risk
reduct
find
suggest
basic
infect
control
measur
good
hand
hygien
practic
reduc
risk
commun
transmiss
nosocomi
transmiss
outbreak
sar
risk
factor
studi
perform
epidem
emphas
import
appropri
use
surgic
mask
respir
consist
wear
surgic
mask
respir
care
patient
protect
nurs
work
two
critic
care
unit
toronto
loeb
et
al
mask
wear
shown
protect
multivari
analysi
casecontrol
studi
conduct
teach
hospit
hong
kong
seto
et
al
risk
develop
sar
time
higher
wear
mask
patient
care
nishiyama
et
al
physic
stabil
sarscov
surviv
day
diarrheal
stool
sampl
alkalin
ph
remain
infecti
respiratori
specimen
day
room
temperatur
lai
et
al
contact
respiratori
secret
signific
risk
factor
sar
transmiss
teleman
et
al
exposur
bodi
fluid
healthcar
worker
eye
mucou
membran
also
associ
increas
risk
transmiss
raboud
et
al
inconsist
use
goggl
gown
glove
cap
associ
higher
risk
infect
lau
et
al
perform
highrisk
patient
care
procedur
intub
manual
ventil
chest
physiotherapi
suction
use
bilevel
posit
airway
pressur
highflow
mechan
ventil
nebul
therapi
associ
nosocomi
transmiss
sar
among
healthcar
worker
toronto
ofneragostini
et
al
particular
endotrach
intub
highrisk
procedur
deserv
investig
casecontrol
studi
conduct
guangzhou
show
incid
sar
among
healthcar
worker
significantli
associ
perform
endotrach
intub
sar
patient
odd
ratio
chen
et
al
retrospect
cohort
studi
identifi
risk
factor
sar
transmiss
among
critic
care
unit
staff
risk
infect
healthcar
worker
either
assist
perform
intub
result
rel
risk
confid
interv
also
interest
note
rel
risk
may
higher
nurs
physician
might
explain
longer
durat
exposur
nurs
like
periintub
period
wherea
physician
exposur
often
limit
procedur
fowler
et
al
fact
proxim
durat
contact
sar
patient
may
associ
higher
risk
viral
transmiss
transmiss
sar
also
occur
person
present
endotrach
intub
includ
one
wore
glove
gown
respir
scale
et
al
aerosolgener
procedur
may
also
contribut
transmiss
sar
infect
occur
healthcar
worker
assist
patient
ventil
bagvalvemask
min
intub
procedur
cardiopulmonari
resuscit
despit
worn
respir
christian
et
al
mechan
transmiss
remain
elucid
howev
transmiss
sarscov
indirect
contact
contamin
environ
might
one
possibl
sarscov
surviv
environ
h
chan
et
al
duan
et
al
infect
retain
day
dri
surfac
rabenau
et
al
hospit
design
augment
air
chang
may
protect
nosocomi
transmiss
sar
hanoi
vietnam
transmiss
hospit
design
isol
ward
larg
spaciou
room
high
ceil
ceil
fan
kept
run
larg
window
kept
open
natur
ventil
infect
rate
sar
among
healthcar
worker
also
correl
ratio
area
ventil
window
area
room
greatest
transmiss
ward
smallest
area
window
result
healthcar
worker
becom
infect
care
one
sar
patient
contrast
ward
highest
ratio
ventil
window
area
room
healthcar
worker
wre
infect
exposur
sar
patient
studi
period
jiang
et
al
numer
nosocomi
outbreak
report
toronto
hong
kong
guangzhou
kaohsiung
singapor
vietnam
sar
epidem
tabl
result
admiss
infect
index
patient
total
secondari
tertiari
case
among
healthcar
worker
outbreak
intens
care
unit
expos
chen
et
al
guangzhou
retrospect
studi
ventil
ward
nosocomi
transmiss
sar
among
type
isol
ward
ratio
area
ventil
window
volum
room
total
time
hospit
h
infect
rate
hcw
area
mention
respect
jiang
et
al
hcw
healthcar
worker
odd
ratio
rr
rel
risk
ci
confid
interv
yen
et
al
taipei
retrospect
studi
serial
infect
control
measur
determin
factor
effect
prevent
nosocomi
infect
hcw
taiwan
checkpoint
alcohol
dispens
gloveon
hand
rub
zone
risk
fever
screen
fever
screen
station
outsid
emerg
depart
signific
method
effect
minim
nosocomi
sar
infect
hcw
p
yen
et
al
hcw
healthcar
worker
odd
ratio
ci
confid
interv
healthcar
worker
infect
scale
et
al
superspread
phenomenon
describ
earliest
nosocomi
outbreak
guangzhou
index
patient
directli
indirectli
transmit
infect
healthcar
worker
within
day
hospit
delay
recognit
symptomat
patient
inappropri
infect
control
measur
import
reason
nosocomi
outbreak
among
outbreak
detail
descript
median
time
admiss
index
patient
patient
isol
design
sar
ward
day
rang
day
gopalakrishna
et
al
liu
et
al
nishiura
et
al
scale
et
al
teleman
et
al
wu
et
al
especi
longer
patient
without
epidemiolog
link
sar
contact
nosocomi
outbreak
recogn
enhanc
infect
control
measur
implement
hospit
mode
transmiss
fulli
understood
initi
phase
sar
epidem
infect
control
measur
vari
center
center
depend
avail
resourc
administr
support
privat
hospit
less
bed
hanoi
vietnam
sar
patient
cohort
use
barrier
precaut
respir
goggl
face
shield
avail
day
outbreak
reynold
et
al
contrast
tertiari
hospit
bed
singapor
respir
glove
gown
goggl
immedi
provid
healthcar
worker
work
emerg
room
intens
care
unit
isol
ward
wherea
power
air
purifi
respir
avail
highrisk
procedur
intub
commun
hospit
toronto
addit
droplet
contact
precaut
care
sar
patient
airborn
infect
isol
ward
healthcar
worker
wore
doubl
glove
doubl
gown
goggl
cap
shoe
cover
worker
isol
ward
intens
care
unit
emerg
room
kaohsiung
taiwan
construct
standard
negativepressur
isol
room
expedit
emerg
room
move
outsid
hospit
complex
patient
triag
hospit
hong
kong
demand
person
protect
equip
high
outbreak
set
provis
healthcar
worker
stratifi
accord
risk
exposur
sar
patient
effort
control
nosocomi
outbreak
respons
includ
temporari
closur
ward
outpati
clinic
inpati
admiss
reynold
et
al
inpati
outpati
servic
nishiura
et
al
varia
et
al
home
quarantin
healthcar
worker
sar
contact
also
mandat
center
gopalakrishna
et
al
median
time
admiss
index
patient
closur
hospit
servic
day
rang
day
wherea
median
time
admiss
index
patient
termin
nosocomi
outbreak
sar
day
rang
day
tabl
howev
still
uncertain
persist
detect
sarscov
rtpcr
specimen
infect
patient
repres
live
viru
shed
actual
contribut
ongo
nosocomi
outbreak
chu
et
al
largest
nosocomi
outbreak
sar
occur
teach
hospit
hong
kong
total
secondari
tertiari
case
epidemiolog
link
male
index
patient
present
ward
march
assum
use
nebul
therapi
index
case
might
contribut
larg
number
secondari
case
overal
attack
rate
sar
among
hospit
inpati
yu
et
al
howev
detail
descript
outbreak
control
retrospect
onsit
inspect
measur
ventil
design
air
distribut
system
bioaerosol
dispers
carri
juli
predict
bioaerosol
concentr
distribut
ward
seem
agre
fairli
well
spatial
infect
pattern
sar
case
even
though
patient
cubicl
posit
pressur
respect
corridor
viruscontain
bioaerosol
gener
eight
nurs
enter
sar
patient
room
infect
probabl
sar
infect
per
shift
work
consist
wear
mask
either
surgic
care
sar
patient
protect
nurs
loeb
et
al
toronto
case
seri
describ
possibl
rout
infect
among
infect
hcw
hospit
perform
highrisk
patient
care
procedur
inconsist
use
person
protect
equip
fatigu
lack
adequ
infect
control
train
like
respons
sar
infect
ofneragostini
et
al
toronto
retrospect
cohort
studi
identifi
intub
specif
risk
factor
sar
transmiss
among
hcw
care
sar
patient
presenc
room
fiberopt
intub
p
hcw
eye
mucou
membran
exposur
bodi
fluid
associ
increas
risk
transmiss
multivari
analysi
p
raboud
et
al
toronto
retrospect
cohort
studi
identifi
intub
specif
risk
factor
sar
transmiss
among
critic
care
staff
risk
ten
critic
care
nurs
respiratori
therapist
physician
probabl
sar
perform
endotrach
intub
rr
ci
p
increas
risk
fowler
et
al
toronto
retrospect
cohort
studi
identifi
intub
specif
risk
factor
sar
transmiss
among
hcw
icu
risk
sar
occur
person
present
endotrach
intub
includ
one
wore
glove
gown
respir
scale
et
al
toronto
case
seri
describ
possibl
transmiss
sar
among
hcw
risk
cpr
healthcar
worker
adopt
contact
droplet
precaut
one
confirm
infect
ventil
bagvalvemask
may
contribut
aerosol
sarscov
christian
et
al
toronto
report
nosocomi
outbreak
control
probabl
suspect
case
sar
includ
hcw
outbreak
control
contact
droplet
precaut
implement
throughout
hospit
march
varia
et
al
ontario
case
seri
identifi
nipp
nebul
medic
specif
risk
factor
sar
transmiss
among
infect
hcw
hcw
unprotect
exposur
index
patient
cpr
cardiopulmonari
resuscit
hcw
healthcar
worker
icu
intens
care
unit
nipp
noninvas
posit
pressur
ventil
odd
ratio
rr
rel
risk
ci
confid
interv
index
patient
cubicl
still
transmit
cubicl
use
comput
fluid
dynam
simul
test
retrospect
analysi
found
air
exchang
relat
small
temperatur
differ
cubicl
might
contribut
sar
transmiss
chen
et
al
view
lack
effect
antivir
therapi
vaccin
infect
control
measur
remain
import
modal
prevent
humantohuman
transmiss
sar
earli
isol
suspect
patient
import
prevent
nosocomi
transmiss
chowel
et
al
hong
kong
patient
triag
emerg
depart
transfer
hospit
evalu
use
set
clinic
epidemiolog
criteria
fever
cough
short
breath
histori
close
contact
sar
case
patient
fulfil
criteria
admit
design
ward
number
bed
cubicl
reduc
allow
bedtob
distanc
least
meter
minim
risk
transmiss
ho
et
al
dedic
team
physician
nurs
led
experienc
respiratori
infecti
diseas
expert
establish
provid
special
care
patient
admit
design
ward
activ
surveil
patient
commun
nosocomi
acquir
pneumonia
also
conduct
gener
ward
identifi
isol
unrecogn
case
standard
contact
droplet
precaut
enforc
clinic
area
hospit
riskstratifi
infect
control
measur
propos
acut
pediatr
ward
hong
kong
stratifi
clinic
area
ultrahigh
highand
moderaterisk
area
accord
differ
risk
level
nosocomi
sar
transmiss
implement
differ
level
infect
control
precaut
nosocomi
transmiss
sar
pediatr
servic
taiwan
integr
infect
control
approach
implement
sar
design
hospit
airborn
infect
isol
room
avail
fever
screen
station
triag
fever
patient
separ
sar
patient
patient
separ
entranc
passageway
patient
healthcar
worker
increas
handwash
facil
demonstr
protect
effect
healthcar
worker
yen
et
al
yen
et
al
besid
infect
control
prepared
emerg
depart
triag
area
gener
ward
design
sar
ward
special
arrang
also
made
oper
room
instanc
reorgan
staff
deploy
made
minim
potenti
exposur
healthcar
worker
physic
modif
ventil
system
done
minim
outflow
contamin
air
oper
room
rest
oper
room
complex
key
arrang
oper
procedur
includ
highrisk
procedur
surgic
tracheostomi
perform
sar
patient
healthcar
worker
oper
room
complex
singapor
without
transmiss
sar
chee
et
al
viral
load
rel
low
initi
phase
symptom
peiri
et
al
time
contact
trace
expos
person
quarantin
effect
control
sar
transmiss
commun
beij
extens
contact
trace
person
quarantin
measur
carri
among
quarantin
close
contact
overal
attack
rate
sar
rang
among
spous
among
work
school
contact
without
measur
sar
might
persist
commun
hospit
pang
et
al
emerg
merscov
middl
east
avian
influenza
infect
china
associ
unusu
high
mortal
rate
chan
et
al
chan
et
al
chan
et
al
chan
et
al
chen
et
al
time
consolid
learnt
sar
adopt
proactiv
infect
control
measur
novel
pathogen
may
emerg
wild
anim
result
close
interact
human
market
restaur
besid
surveil
anim
sourc
lau
et
al
poon
et
al
wong
et
al
even
import
enhanc
clinic
awar
earli
recognit
infect
caus
novel
microbi
agent
appropri
infect
control
measur
provis
person
protect
equip
isol
patient
implement
earli
advanc
laboratori
technolog
diagnost
test
perform
within
short
period
time
fact
success
implement
action
outbreak
pandem
influenza
thu
prevent
occurr
nosocomi
outbreak
hospit
cheng
et
al
cheng
et
al
rapid
laboratori
diagnost
test
integr
proactiv
infect
control
measur
variou
bacteria
virus
potenti
nosocomi
outbreak
cheng
et
al
cheng
et
al
cheng
et
al
introduct
sophist
molecular
sequenc
techniqu
also
facilit
investig
outbreak
pseudooutbreak
caus
unusu
pathogen
cheng
et
al
cheng
et
al
et
al
sar
affect
larg
number
healthcar
worker
fatal
cooper
et
al
protect
import
aspect
infect
control
train
addit
patient
safeti
hand
hygien
use
alcoholbas
hand
rub
becom
key
infect
control
measur
promot
hand
hygien
introduc
concept
directlyobserv
hand
hygien
electron
monitor
complianc
cheng
et
al
cheng
et
al
result
better
control
endem
sporad
pathogen
hospit
cheng
et
al
cheng
et
al
concept
extens
contact
trace
sar
outbreak
har
control
multipl
drugresist
organ
yet
endem
healthcar
set
cheng
et
al
cheng
et
al
ten
year
sar
outbreak
healthcar
system
better
prepar
new
challeng
pose
known
unknown
emerg
pathogen
